IART - Integra LifeSciences Holdings Corporation Stock Price, News & Analysis

$47.58 -0.16 (-0.34 %)
(As of 11/24/2017 04:03 AM ET)
Previous Close$47.74
Today's Range$47.30 - $47.79
52-Week Range$37.71 - $56.42
Volume429,500 shs
Average Volume606,088 shs
Market Capitalization$3.73 billion
P/E Ratio26.29
Dividend YieldN/A
Beta0.64

About Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Integra LifeSciences Holdings Corporation logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.


Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:IART
CUSIP45798520

Debt

Debt-to-Equity Ratio1.26%
Current Ratio4.49%
Quick Ratio3.39%

Price-To-Earnings

Trailing P/E Ratio26.29
Forward P/E Ratio25.44
P/E Growth2.07

Sales & Book Value

Annual Sales$992.08 million
Price / Sales3.76
Cash Flow$2.81 per share
Price / Cash16.91
Book Value$11.64 per share
Price / Book4.09

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS$0.61
Net Income$74.56 million
Net Margins4.52%
Return on Equity16.35%
Return on Assets6.83%

Miscellaneous

Employees3,700
Outstanding Shares78,480,000

Frequently Asked Questions for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

What is Integra LifeSciences Holdings Corporation's stock symbol?

Integra LifeSciences Holdings Corporation trades on the NASDAQ under the ticker symbol "IART."

When did Integra LifeSciences Holdings Corporation's stock split? How did Integra LifeSciences Holdings Corporation's stock split work?

Integra LifeSciences Holdings Corporation's stock split on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly minted shares were payable to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of Integra LifeSciences Holdings Corporation stock prior to the split would have 200 shares after the split.

How were Integra LifeSciences Holdings Corporation's earnings last quarter?

Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced its earnings results on Thursday, October, 26th. The life sciences company reported $0.45 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.47 by $0.02. The life sciences company earned $278.83 million during the quarter, compared to the consensus estimate of $286 million. Integra LifeSciences Holdings Corporation had a net margin of 4.52% and a return on equity of 16.35%. The company's revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.93 earnings per share. View Integra LifeSciences Holdings Corporation's Earnings History.

When will Integra LifeSciences Holdings Corporation make its next earnings announcement?

Integra LifeSciences Holdings Corporation is scheduled to release their next quarterly earnings announcement on Thursday, February, 22nd 2018. View Earnings Estimates for Integra LifeSciences Holdings Corporation.

Where is Integra LifeSciences Holdings Corporation's stock going? Where will Integra LifeSciences Holdings Corporation's stock price be in 2017?

10 equities research analysts have issued 1 year target prices for Integra LifeSciences Holdings Corporation's stock. Their predictions range from $44.00 to $65.00. On average, they anticipate Integra LifeSciences Holdings Corporation's share price to reach $53.33 in the next twelve months. View Analyst Ratings for Integra LifeSciences Holdings Corporation.

Who are some of Integra LifeSciences Holdings Corporation's key competitors?

Who are Integra LifeSciences Holdings Corporation's key executives?

Integra LifeSciences Holdings Corporation's management team includes the folowing people:

  • Stuart M. Essig Ph.D., Independent Chairman of the Board (Age 55)
  • Peter J. Arduini, President, Chief Executive Officer, Director (Age 52)
  • Glenn G. Coleman, Chief Financial Officer, Corporate Vice President (Age 49)
  • Lisa Evoli, Corporate Vice President, Chief Human Resources Officer (Age 47)
  • Jeffrey Mosebrook, Principal Accounting Officer, Vice President, Corporate Controller (Age 41)
  • Kenneth Burhop Ph.D., Chief Scientific Officer, Corporate Vice President (Age 63)
  • John Mooradian, Corporate Vice President - Global Operations and Supply Chain (Age 61)
  • Richard D. Gorelick, Corporate Vice President, General Counsel, Administration, Secretary (Age 56)
  • Robert T. Davis Jr., Corporate Vice President, President — Specialty Surgical Solutions (Age 58)
  • Judith E. O'Grady R.N., Corporate Vice President - Global Regulatory Affairs (Age 66)

Who owns Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Janus Henderson Group PLC (2.59%), Dimensional Fund Advisors LP (1.89%), Orbimed Advisors LLC (1.39%), Jennison Associates LLC (1.32%), Fisher Asset Management LLC (1.29%) and Vaughan Nelson Investment Management L.P. (1.15%). Company insiders that own Integra LifeSciences Holdings Corporation stock include Barbara B Hill, Christian S Schade, Daniel L Reuvers, Donald E Morel Jr, Glenn Coleman, James M Sullivan, Jeffrey Mosebrook, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Institutional Ownership Trends for Integra LifeSciences Holdings Corporation.

Who sold Integra LifeSciences Holdings Corporation stock? Who is selling Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Wells Fargo & Company MN, Hood River Capital Management LLC, Victory Capital Management Inc., Boston Partners, Dimensional Fund Advisors LP, Artisan Partners Limited Partnership and BNP Paribas Arbitrage SA. Company insiders that have sold Integra LifeSciences Holdings Corporation company stock in the last year include Glenn Coleman, James M Sullivan, Jeffrey Mosebrook, Richard D Gorelick and Stuart Essig. View Insider Buying and Selling for Integra LifeSciences Holdings Corporation.

Who bought Integra LifeSciences Holdings Corporation stock? Who is buying Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Jennison Associates LLC, Chartwell Investment Partners LLC, Westfield Capital Management Co. LP, Sei Investments Co., Sector Gamma AS, First Trust Advisors LP and Schwab Charles Investment Management Inc.. Company insiders that have bought Integra LifeSciences Holdings Corporation stock in the last two years include Barbara B Hill and Donald E Morel Jr. View Insider Buying and Selling for Integra LifeSciences Holdings Corporation.

How do I buy Integra LifeSciences Holdings Corporation stock?

Shares of Integra LifeSciences Holdings Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Integra LifeSciences Holdings Corporation's stock price today?

One share of Integra LifeSciences Holdings Corporation stock can currently be purchased for approximately $47.58.

How big of a company is Integra LifeSciences Holdings Corporation?

Integra LifeSciences Holdings Corporation has a market capitalization of $3.75 billion and generates $992.08 million in revenue each year. The life sciences company earns $74.56 million in net income (profit) each year or $0.61 on an earnings per share basis. Integra LifeSciences Holdings Corporation employs 3,700 workers across the globe.

How can I contact Integra LifeSciences Holdings Corporation?

Integra LifeSciences Holdings Corporation's mailing address is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. The life sciences company can be reached via phone at 609-275-0500 or via email at [email protected]


MarketBeat Community Rating for Integra LifeSciences Holdings Corporation (IART)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  265 (Vote Outperform)
Underperform Votes:  270 (Vote Underperform)
Total Votes:  535
MarketBeat's community ratings are surveys of what our community members think about Integra LifeSciences Holdings Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 4 Hold Ratings, 6 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $53.33 (12.09% upside)

Consensus Price Target History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Price Target History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Analysts' Ratings History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/9/2017Royal Bank Of CanadaReiterated RatingSector Perform -> Sector Perform$48.00 -> $50.00N/AView Rating Details
10/29/2017Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
10/29/2017Jefferies Group LLCReiterated RatingBuy$56.00N/AView Rating Details
10/27/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$44.00N/AView Rating Details
10/26/2017Oppenheimer Holdings, Inc.Reiterated RatingBuyN/AView Rating Details
9/12/2017Barclays PLCReiterated RatingEqual Weight$47.00 -> $53.00HighView Rating Details
7/27/2017Raymond James Financial, Inc.Boost Price TargetOutperform$51.00 -> $55.00LowView Rating Details
7/26/2017Cantor FitzgeraldSet Price TargetBuy$65.00LowView Rating Details
3/22/2017Piper Jaffray CompaniesReiterated RatingOverweight$47.00LowView Rating Details
1/6/2017JMP SecuritiesUpgradeMarket Perform -> Outperform$50.00N/AView Rating Details
10/28/2016Lake Street CapitalUpgradeHold -> Buy$46.00N/AView Rating Details
9/23/2016ArgusBoost Price TargetBuy$45.00 -> $52.50N/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Earnings by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Earnings History by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ IART)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2018        
10/26/2017Q3 2017$0.47$0.45$286.00 million$278.83 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.45$0.45$283.58 million$282.16 millionViewN/AView Earnings Details
4/26/2017Q1 17$0.40$0.39$254.19 million$258.60 millionViewN/AView Earnings Details
2/23/2017Q4 2016$0.52$0.52$257.27 million$255.70 millionViewN/AView Earnings Details
10/27/2016Q3$0.89$0.93$249.30 million$250.30 millionViewListenView Earnings Details
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details
7/30/2015Q215$0.73$0.79$239.91 million$244.10 millionViewListenView Earnings Details
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details
8/5/2014Q214$0.63$0.68$229.32 million$231.40 millionViewN/AView Earnings Details
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details
10/24/2012$0.77$0.85ViewN/AView Earnings Details
7/26/2012$0.69$0.74ViewN/AView Earnings Details
4/25/2012$0.60$0.71ViewN/AView Earnings Details
2/23/2012$0.55$0.72ViewN/AView Earnings Details
10/31/2011$0.77$0.77ViewN/AView Earnings Details
7/28/2011$0.61$0.70ViewN/AView Earnings Details
4/28/2011$0.66$0.66ViewN/AView Earnings Details
2/24/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
2017 EPS Consensus Estimate: $1.89
2018 EPS Consensus Estimate: $2.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.38$0.48$0.42
Q2 20174$0.43$0.47$0.45
Q3 20174$0.42$0.50$0.46
Q4 20174$0.55$0.60$0.57
Q1 20183$0.45$0.51$0.47
Q2 20183$0.54$0.56$0.55
Q3 20183$0.57$0.60$0.58
Q4 20183$0.61$0.70$0.65
Q1 20191$0.54$0.54$0.54
Q2 20191$0.62$0.62$0.62
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Integra LifeSciences Holdings Corporation (NASDAQ IART)

Insider Ownership Percentage: 21.50%
Institutional Ownership Percentage: 83.99%
Insider Trades by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Insider Trades by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Insider Trades by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ IART)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/20/2017Jeffrey MosebrookInsiderSell160$47.41$7,585.60View SEC Filing  
11/14/2017Richard D GorelickVPSell1,500$47.19$70,785.00View SEC Filing  
10/31/2017Barbara B HillDirectorBuy10,768$46.66$502,434.88View SEC Filing  
8/4/2017Donald E Morel JrDirectorBuy10,000$49.25$492,500.00View SEC Filing  
8/3/2017Donald E Morel JrDirectorBuy2,500$49.29$123,225.00View SEC Filing  
8/1/2017Barbara B HillDirectorBuy5,050$49.33$249,116.50View SEC Filing  
5/25/2017Stuart EssigDirectorSell135,000$49.90$6,736,500.00View SEC Filing  
5/23/2017Stuart EssigDirectorSell140,000$48.01$6,721,400.00View SEC Filing  
5/4/2017Glenn ColemanVPSell13,865$45.91$636,542.15View SEC Filing  
5/4/2017James M SullivanDirectorSell15,658$45.89$718,545.62View SEC Filing  
11/8/2016Peter J ArduiniCEOSell24,009$79.51$1,908,955.59View SEC Filing  
8/23/2016Raymond G MurphyDirectorSell2,600$86.64$225,264.00View SEC Filing  
8/9/2016Peter J ArduiniCEOSell24,009$84.52$2,029,240.68View SEC Filing  
8/4/2016Raymond G MurphyDirectorSell2,610$84.83$221,406.30View SEC Filing  
8/1/2016Richard D GorelickVPSell4,000$84.60$338,400.00View SEC Filing  
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Integra LifeSciences Holdings Corporation (NASDAQ IART)

Source:
DateHeadline
Integra LifeSciences Holdings Co. (IART) Receives Consensus Recommendation of "Buy" from AnalystsIntegra LifeSciences Holdings Co. (IART) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 19 at 11:54 AM
Analyzing VWR Corporation (VWR) & Integra LifeSciences Holdings (IART)Analyzing VWR Corporation (VWR) & Integra LifeSciences Holdings (IART)
www.americanbankingnews.com - November 19 at 9:40 AM
ETFs with exposure to Integra LifeSciences Holdings Corp. : November 16, 2017ETFs with exposure to Integra LifeSciences Holdings Corp. : November 16, 2017
finance.yahoo.com - November 17 at 5:22 AM
Insider Selling: Integra LifeSciences Holdings Corporation (IART) VP Sells 1,500 Shares of StockInsider Selling: Integra LifeSciences Holdings Corporation (IART) VP Sells 1,500 Shares of Stock
www.americanbankingnews.com - November 15 at 10:29 PM
Integra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $361.17 MillionIntegra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $361.17 Million
www.americanbankingnews.com - November 12 at 3:08 AM
Integra Gains on Global Growth, Hurricanes Hamper BusinessIntegra Gains on Global Growth, Hurricanes Hamper Business
finance.yahoo.com - November 3 at 8:24 AM
ETFs with exposure to Integra LifeSciences Holdings Corp. : November 2, 2017ETFs with exposure to Integra LifeSciences Holdings Corp. : November 2, 2017
finance.yahoo.com - November 3 at 8:24 AM
Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Integra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 2 at 1:32 AM
Insider Buying: Integra LifeSciences Holdings Corporation (IART) Director Purchases 10,768 Shares of StockInsider Buying: Integra LifeSciences Holdings Corporation (IART) Director Purchases 10,768 Shares of Stock
www.americanbankingnews.com - November 1 at 5:44 PM
Integra LifeSciences Holdings Corporation (IART) Forecasted to Earn FY2017 Earnings of $1.86 Per ShareIntegra LifeSciences Holdings Corporation (IART) Forecasted to Earn FY2017 Earnings of $1.86 Per Share
www.americanbankingnews.com - November 1 at 9:38 AM
Northcoast Research Weighs in on Integra LifeSciences Holdings Corporations Q3 2018 Earnings (IART)Northcoast Research Weighs in on Integra LifeSciences Holdings Corporation's Q3 2018 Earnings (IART)
www.americanbankingnews.com - October 31 at 2:02 PM
Integra LifeSciences Holdings Corporation (IART) to Post FY2019 Earnings of $2.59 Per Share, Oppenheimer Holdings ForecastsIntegra LifeSciences Holdings Corporation (IART) to Post FY2019 Earnings of $2.59 Per Share, Oppenheimer Holdings Forecasts
www.americanbankingnews.com - October 30 at 11:52 AM
Wells Fargo & Company Downgrades Integra LifeSciences Holdings Corporation (IART) to Market PerformWells Fargo & Company Downgrades Integra LifeSciences Holdings Corporation (IART) to Market Perform
www.americanbankingnews.com - October 30 at 12:46 AM
Integra LifeSciences Holdings Corporation 2017 Q3 - Results - Earnings Call SlidesIntegra LifeSciences Holdings Corporation 2017 Q3 - Results - Earnings Call Slides
seekingalpha.com - October 28 at 8:09 PM
Integra LifeSciences Holdings Corporation (IART) Stock Rating Lowered by TheStreetIntegra LifeSciences Holdings Corporation (IART) Stock Rating Lowered by TheStreet
www.americanbankingnews.com - October 28 at 10:16 AM
Edited Transcript of IART earnings conference call or presentation 26-Oct-17 12:30pm GMTEdited Transcript of IART earnings conference call or presentation 26-Oct-17 12:30pm GMT
finance.yahoo.com - October 27 at 6:27 AM
Integra LifeSciences Holdings Corporation (IART) Receives Buy Rating from Oppenheimer Holdings, Inc.Integra LifeSciences Holdings Corporation (IART) Receives Buy Rating from Oppenheimer Holdings, Inc.
www.americanbankingnews.com - October 26 at 4:08 PM
Integra LifeSciences Holdings Corporation (IART) Announces  Earnings ResultsIntegra LifeSciences Holdings Corporation (IART) Announces Earnings Results
www.americanbankingnews.com - October 26 at 12:34 PM
Integra Lifesciences Earns RS Rating UpgradeIntegra Lifesciences Earns RS Rating Upgrade
finance.yahoo.com - October 26 at 12:32 PM
Integra LifeSciences Reports Third Quarter 2017 Financial ResultsIntegra LifeSciences Reports Third Quarter 2017 Financial Results
finance.yahoo.com - October 26 at 12:32 PM
Integra misses Street 3Q forecastsIntegra misses Street 3Q forecasts
finance.yahoo.com - October 26 at 12:32 PM
INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings CallINTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call
finance.yahoo.com - October 26 at 12:32 PM
Zacks Investment Research Lowers Integra LifeSciences Holdings Corporation (IART) to HoldZacks Investment Research Lowers Integra LifeSciences Holdings Corporation (IART) to Hold
www.americanbankingnews.com - October 25 at 7:52 PM
Integra LifeSciences Holdings Corporation (IART) Receives Average Recommendation of "Buy" from BrokeragesIntegra LifeSciences Holdings Corporation (IART) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 25 at 3:42 PM
Integra LifeSciences Holdings Corporation (IART) versus The Competition Financial AnalysisIntegra LifeSciences Holdings Corporation (IART) versus The Competition Financial Analysis
www.americanbankingnews.com - October 25 at 8:37 AM
Integra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $286.27 MillionIntegra LifeSciences Holdings Corporation (IART) Expected to Announce Quarterly Sales of $286.27 Million
www.americanbankingnews.com - October 24 at 3:46 PM
Integra LifeSciences Holdings Corporation (IART) Expected to Post Earnings of $0.47 Per ShareIntegra LifeSciences Holdings Corporation (IART) Expected to Post Earnings of $0.47 Per Share
www.americanbankingnews.com - October 22 at 4:26 AM
Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : October 19, 2017Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : October 19, 2017
finance.yahoo.com - October 19 at 11:19 PM
Integra LifeSciences Holdings Corporation (IART) to Release Quarterly Earnings on ThursdayIntegra LifeSciences Holdings Corporation (IART) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - October 19 at 4:46 AM
Integra LifeSciences Holdings Corporation to Post Q3 2017 Earnings of $0.45 Per Share, Northcoast Research Forecasts (IART)Integra LifeSciences Holdings Corporation to Post Q3 2017 Earnings of $0.45 Per Share, Northcoast Research Forecasts (IART)
www.americanbankingnews.com - October 16 at 2:14 AM
Integra LifeSciences Holdings Corporations (IART) "Buy" Rating Reaffirmed at Jefferies Group LLCIntegra LifeSciences Holdings Corporation's (IART) "Buy" Rating Reaffirmed at Jefferies Group LLC
www.americanbankingnews.com - October 15 at 5:50 PM
Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference ...Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference ...
www.nasdaq.com - October 12 at 6:11 AM
Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017Integra LifeSciences to Host Third Quarter 2017 Earnings Results Conference Call on October 26, 2017
finance.yahoo.com - October 12 at 6:11 AM
Integra LifeSciences Holdings Corporation (IART) Upgraded to Buy by Zacks Investment ResearchIntegra LifeSciences Holdings Corporation (IART) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - October 10 at 4:34 PM
Integras (IART) Revize/Revize-X Boosts Tissue Technology ArmIntegra's (IART) Revize/Revize-X Boosts Tissue Technology Arm
finance.yahoo.com - October 10 at 12:46 AM
Integra LifeSciences Holdings Corporation (IART) Cut to Hold at Zacks Investment ResearchIntegra LifeSciences Holdings Corporation (IART) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - October 9 at 1:22 PM
Integra LifeSciences launches Revize™/ Revize™-X Collagen Matrix for Plastic and Reconstructive SurgeryIntegra LifeSciences launches Revize™/ Revize™-X Collagen Matrix for Plastic and Reconstructive Surgery
finance.yahoo.com - October 6 at 8:09 PM
Integra LifeSciences SurgiMend PRS Meshed Boosts ADM LineIntegra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line
finance.yahoo.com - October 5 at 11:10 AM
 Analysts Expect Integra LifeSciences Holdings Corporation (IART) Will Post Quarterly Sales of $286.77 Million Analysts Expect Integra LifeSciences Holdings Corporation (IART) Will Post Quarterly Sales of $286.77 Million
www.americanbankingnews.com - October 5 at 10:36 AM
Integra LifeSciences launches SurgiMend® PRS Meshed Collagen Matrix for Plastic and Reconstructive SurgeryIntegra LifeSciences launches SurgiMend® PRS Meshed Collagen Matrix for Plastic and Reconstructive Surgery
finance.yahoo.com - October 4 at 4:01 PM
Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bearish Manner : IART-US : October 4, 2017Integra LifeSciences Holdings Corp. breached its 50 day moving average in a Bearish Manner : IART-US : October 4, 2017
finance.yahoo.com - October 4 at 4:01 PM
Integra LifeSciences' SurgiMend PRS Meshed Boosts ADM LineIntegra LifeSciences' SurgiMend PRS Meshed Boosts ADM Line
finance.yahoo.com - October 4 at 4:01 PM
Integra LifeSciences Launches Integra® SurgiMend™ PRS Meshed Collagen Matrix for Breast Reconstruction in EuropeIntegra LifeSciences Launches Integra® SurgiMend™ PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
finance.yahoo.com - October 3 at 9:52 AM
Integra LifeSciences Launches Integra® SurgiMend(TM) PRS Meshed Collagen Matrix for Breast Reconstruction in EuropeIntegra LifeSciences Launches Integra® SurgiMend(TM) PRS Meshed Collagen Matrix for Breast Reconstruction in Europe
finance.yahoo.com - October 3 at 9:52 AM
Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & JohnsonIntegra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson
finance.yahoo.com - October 2 at 6:33 PM
FTC allows Integra to buy J&J’s Codman neuro business, with conditionsFTC allows Integra to buy J&J’s Codman neuro business, with conditions
www.reuters.com - September 28 at 3:44 PM
BRIEF-Integra lifesciences reports preliminary assessment of damage to Puerto Rico facilityBRIEF-Integra lifesciences reports preliminary assessment of damage to Puerto Rico facility
www.reuters.com - September 26 at 10:45 AM
Form 8-K INTEGRA LIFESCIENCES For: Sep 26Form 8-K INTEGRA LIFESCIENCES For: Sep 26
www.streetinsider.com - September 26 at 10:45 AM
Integra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market StudyIntegra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market Study
finance.yahoo.com - September 22 at 2:13 PM
Integra LifeSciences Holdings Corp. – Value Analysis (NASDAQ:IART) : September 21, 2017Integra LifeSciences Holdings Corp. – Value Analysis (NASDAQ:IART) : September 21, 2017
finance.yahoo.com - September 22 at 2:13 PM

Social Media

Financials

Chart

Integra LifeSciences Holdings Corporation (NASDAQ IART) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.